Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Liu-Shan Yang, Wen-Sen Wu, Fu Zhang, Yi Jiang, Yue Fan, Heng-Xiao Fang & Ju Long. (2014) Role of toll-like receptors in lung cancer. Journal of Receptors and Signal Transduction 34:5, pages 342-344.
Read now
Read now
Chun Wai Mai, Yew Beng Kang & Mallikarjuna Rao Pichika. (2013) Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. OncoTargets and Therapy 6, pages 1573-1587.
Read now
Read now
Articles from other publishers (13)
Anne Sadewasser, Erik Dietzel, Sven Michel, Michael Klüver, Markus Helfer, Tamara Thelemann, Richard Klar, Markus Eickmann, Stephan Becker & Frank Jaschinski. (2019) Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro. Molecular Therapy - Nucleic Acids 16, pages 686-697.
Crossref
Crossref
Cong Ding, Li Li, Yi Zhang, Zhenyu Ji, Chenglong Zhang, Taotao Liang, Xun Guo, Xin Liu & Qiaozhen Kang. (2018) Toll‑like receptor agonist rMBP‑NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer. Oncology Letters.
Crossref
Crossref
Jung Eun Koo, Seung Won Shin, Soong Ho Um & Joo Young Lee. (2015) X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes. Molecular Cancer 14:1.
Crossref
Crossref
Zengguang Xu, Fengying Wu, Chunhong Wang, Xiyu Liu, Baoli Kang, Shan Shan, Xia Gu, Kailing Wang & Tao Ren. (2014) The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy. Cancer Cell International 14:1.
Crossref
Crossref
Sarang Tartey & Osamu Takeuchi. 2014. Cancer and Inflammation Mechanisms. Cancer and Inflammation Mechanisms
83
102
.
Karim H. Shalaby. 2014. Immunology of Aging. Immunology of Aging
87
143
.
Zeng-Zhen Lai, Ni-Zhang, Xiao-Ling Pan & Liang Song. (2013)
Toll-like receptor 9 (
TLR9
) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer
. Journal of International Medical Research 41:4, pages 1027-1036.
Crossref
Crossref
Qinchuan Li, Yang Han, Guangru Fei, Zhongliang Guo, Tao Ren & Zhongmin Liu. (2012) IL-17 promoted metastasis of non-small-cell lung cancer cells. Immunology Letters 148:2, pages 144-150.
Crossref
Crossref
Lin Xu, Chunhong Wang, Ya Zhou, Tao Ren & Zhenke Wen. (2012) CpG oligonucleotides induce the differentiation of CD4+Th17 cells by triggering plasmacytoid dendritic cells in adoptively cell transfer immunotherapy. Immunology Letters 142:1-2, pages 55-63.
Crossref
Crossref
Arash Pourgholaminejad, Arezoo Jamali, Morteza Samadi-Foroushani, Afshin Amari, Reza Mirzaei, Bita Ansaripour, Nemat Khansari, Mohammad Reza Aghasadeghi, Babak Baban & Jamshid Hadjati. (2011) Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model. Cellular Immunology 271:2, pages 360-364.
Crossref
Crossref
Lin Xu, Chunhong Wang, Zhenke Wen, Ya Zhou, Zhongmin Liu, Yongjie Liang, Zengguang Xu & Tao Ren. (2010) CpG Oligodeoxynucleotides Enhance the Efficacy of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes by Modifying the Th1 Polarization and Local Infiltration of Th17 Cells. Clinical and Developmental Immunology 2010, pages 1-9.
Crossref
Crossref
Yanal M. Murad & Timothy M. Clay. (2009) CpG Oligodeoxyneucleotides as TLR9 Agonists. BioDrugs 23:6, pages 361-375.
Crossref
Crossref
Anna Wolska, Ewa Lech-Marańda & Tadeusz Robak. (2009) Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cellular and Molecular Biology Letters 14:2.
Crossref
Crossref